Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yu, Chenchen"'
Autor:
Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA., Montefiori DC; Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Deng W; Moderna, Inc., Cambridge, MA, USA., Zhou H; Moderna, Inc., Cambridge, MA, USA., Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Castellino F; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., O'Connell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., McDanal C; Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Eaton A; Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Sarzotti-Kelsoe M; Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., van der Laan LWP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hejazi NS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Biostatistics, School of Public Health, University of California Berkeley, Berkeley, CA, USA., Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Miller J; Moderna, Inc., Cambridge, MA, USA., El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Baden LR; Brigham and Women's Hospital, Boston, MA, USA., Baron M; Palm Beach Research Center, West Palm Beach, FL, USA., De La Cruz L; Keystone Vitalink Research, Greenville, SC, USA., Gay C; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Kalams S; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Kelley CF; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and the Grady Health System, Atlanta, GA, USA., Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Pajon R; Moderna, Inc., Cambridge, MA, USA., Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2022 Jan 07; Vol. 375 (6576), pp. 43-50. Date of Electronic Publication: 2021 Nov 23.
Autor:
Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America., Laher F; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Maganga L; NIMR-Mbeya Medical Research Center, Mbeya, Tanzania., Herce ME; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Naidoo S; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa., Hosseinipour MC; UNC Project Malawi, Lilongwe, Malawi., Innes C; Aurum Institute, Klerksdorp, South Africa., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Mann P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Yates NL; Duke Human Vaccine Institute, Department of Surgery Duke University, Durham, North Carolina, United States of America., Heptinstall J; Duke Human Vaccine Institute, Department of Surgery Duke University, Durham, North Carolina, United States of America., Mkhize NN; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa., Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Center Research Institute of South Africa, Cape Town, South Africa., Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Allen M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland United States of America., Hutter J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland United States of America., Wagner R; Institute of Medical Microbiology and Hygiene, University of Regensberg, Regensberg, Germany., Pantaleo G; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Tomaras GD; Duke Human Vaccine Institute, Department of Surgery Duke University, Durham, North Carolina, United States of America., Morris L; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa., Montefiori DC; Duke Human Vaccine Institute, Department of Surgery Duke University, Durham, North Carolina, United States of America., Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Cape Town HVTN Immunology Laboratory, Hutchinson Center Research Institute of South Africa, Cape Town, South Africa., Gray GE; South African Medical Research Council, Cape Town, South Africa., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Publikováno v:
PLoS medicine [PLoS Med] 2020 May 22; Vol. 17 (5), pp. e1003117. Date of Electronic Publication: 2020 May 22 (Print Publication: 2020).
Autor:
Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Allen M; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Yates NL; Departments of Surgery and Immunology, Duke Human Vaccine Institute, Durham, North Carolina, United States of America., Morris L; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Malahleha M; Setshaba Research Centre, Soshanguve, South Africa., Mngadi K; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Daniels B; South African Medical Research Council, Durban, South Africa., Innes C; Aurum Institute, Klerksdorp Research Centre, Klerksdorp, South Africa., Saunders K; Departments of Surgery and Immunology, Duke Human Vaccine Institute, Durham, North Carolina, United States of America., Grant S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Phogat S; Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America., DiazGranados CA; Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America., Koutsoukos M; GSK Vaccines, Rixensart, Belgium., Van Der Meeren O; GSK Vaccines, Rixensart, Belgium., Bentley C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Mkhize NN; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Pensiero MN; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Mehra VL; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Montefiori DC; Departments of Surgery and Immunology, Duke Human Vaccine Institute, Durham, North Carolina, United States of America., Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council, Durban, South Africa., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Tomaras GD; Departments of Surgery and Immunology, Duke Human Vaccine Institute, Durham, North Carolina, United States of America.
Publikováno v:
PLoS medicine [PLoS Med] 2020 Feb 24; Vol. 17 (2), pp. e1003038. Date of Electronic Publication: 2020 Feb 24 (Print Publication: 2020).
Autor:
Kolawole AO; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA., Xia C; Donald Danforth Plant Science Center, St Louis, MO, USA., Li M; Donald Danforth Plant Science Center, St Louis, MO, USA., Gamez M; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA., Yu C; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA., Rippinger CM; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA., Yucha RE; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA., Smith TJ; Donald Danforth Plant Science Center, St Louis, MO, USA., Wobus CE; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.
Publikováno v:
The Journal of general virology [J Gen Virol] 2014 Sep; Vol. 95 (Pt 9), pp. 1958-1968. Date of Electronic Publication: 2014 Jun 04.
Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization.
Autor:
Kolawole AO; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Li M, Xia C, Fischer AE, Giacobbi NS, Rippinger CM, Proescher JB, Wu SK, Bessling SL, Gamez M, Yu C, Zhang R, Mehoke TS, Pipas JM, Wolfe JT, Lin JS, Feldman AB, Smith TJ, Wobus CE
Publikováno v:
Journal of virology [J Virol] 2014 Apr; Vol. 88 (8), pp. 4543-57. Date of Electronic Publication: 2014 Feb 05.